Exam 1 Flashcards
Lidocaine composition that we use
2% lidocaine with 1:100,000 epinephrine
Halflife: 1.6
Short duration anesthetic we use
3% mepivicaine without vasoconstrictor
Halflife: 1.9
Intermediate duration anesthetic we use
4% articaine with 1:100,000 epinephrine
Halflife: 0.5
Long duration anesthetic we use
0.5% bupivacaine with 1:200,000 epinephrine
Halflife: 3.5
Antioxidant used in anesthetics
(with vasoconstrictors only)
sodium metabisulfite
Preservative used in anesthetics
(multidose vials only)
methylparaben
pH adjusting agents
HCl, NaOH
pH is usually acidic (4-6) especially with vasoconstrictors
What gylcoprotein has a higher protein binding affinity for lidocaine?
Alpha1-acid Glycoprotein (AGP, AAG)
What conditions increase alpha1-acid glycoprotein?
uremia, jaundice, pregnancy, or HIV infection
but might not have any clinical significance in binding of lidocaine
Unbound Drug Tissue Distribution
Rapid uptake by lungs (1 minute)
Brain, heart, liver, kidneys (5 minutes)
Muscle (15 minutes)
Fat (1-2 hours)
Ester-type anesthetics metabolism and excretion
circulating plasma pseudocholinesterase, renal excretion
Amide-type metabolism and excretion
AND EXCEPTIONS
hepatic metabolism, renal excretion
Exceptions:
-prilocaine has significant extrahepatic metabolism
-articaine is partly metabolized by pseudocholinesterase
Effects of lidocaine on CNS:
General Effects
Sedation
Disinhibition
-But low doses act like excitation
Effects of lidocaine on CNS:
Low doses
anticonvulsant activity
mild relaxation/sedation
generalized analgesia
Effects of lidocaine on CNS:
Moderate doses
euphoria lightheadedness dysphoria slurred speech drowsiness sensory changes (blurred, double vision) twitching
Effects of lidocaine on CNS:
Moderate to high doses
disorientation
tremor
unconsciousness
seizures
Effects of lidocaine on CNS:
high doses
Coma
Respiratory arrest
Effects on vasculature (LOCAL)
Vasodilation at local injection site
direct inhibition of vascular smooth muscle tone
bupivacaine > lidocaine > mepivacaine
Effects on vasculature (SYSTEMIC)
Low concentrations - mild increase in peripheral vascular resistance
Moderate concentrations - central effects predominate
decreased heart rate, cardiac output, PVR
Higher concentrations - systemic vasodilation and decreased resistance
Do more lipophillic drugs have a higher rxn with CV effects or CNS?
more lipophilic drugs have proportionally greater cardiovascular than CNS effects
Cardiac effects
Higher concentrations decrease: conduction velocity automaticity myocardial contractility cardiac output blood pressure
Are systemic effects of local anesthetics overshadowed by vasoconstrictor effects?
yes
Presynaptic Reuptake and metabolism
Leakage out of vesicles into cytoplasm – an active equilibrium
Degradation by MAO within the neuron
Hepatic degradation
by COMT
Now thought to be a relatively minor pathwa
alpha1 receptor
Area, Action, clinical effect
Vascular system (excitatory) Action: Vasoconstriction Clinical effect: increase BP
Beta1
Area, Action, clinical effect
– Heart (and small intestine)
Action: Increased heart rate and force of contraction
Clinical effect: increase heart rate
Beta2
Area, Action, clinical effect
– Vascular, pulmonary systems (inhibitory)
Action: Vasodilation in skeletal muscle
Clinical effect: Decrease BP
Alpha 2
Only action
Action: Inhibits release of norepinephrine
(presynaptic feedback inhibition)
Why do we use a vasoconstrictor?
3 reasons
- Improve local retention of anesthetic
- enhance local anesthetic effect
- prolong duration - Provide local hemostasis for surgery
- (Reduce systemic toxicity)
Effects of vasoconstrictor on Heart
Heart - increase contractility, rate, output
BUT net decrease in efficiency